Trianni and Zoetis Announce Agreement to Develop a Transgenic Antibody Discovery Platform for Use in Animal Health

 July 7, 2020 | Trianni, Inc. (TRIANNI) and Zoetis announced a collaboration for the development of transgenic monoclonal antibody platforms for the discovery of new veterinary treatments. “We are confident that the application of TRIANNI’s proven transgenic human monoclonal antibody discovery platform technology to the veterinary field will add value to Zoetis’ product development programs,” […]